Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Adler

Showing results (811-820 of 830) with videos related to

Pageof 83
Sort By:
Brain Communications|June 15, 2026
Dose-dependent white matter changes associated with repetitive head impacts in former American football playersHector Arciniega, Alana Wickham, Brian Szekely, et al.
Science Translational Medicine|October 8, 2010
PGC-1α, a potential therapeutic target for early intervention in Parkinson's diseaseBin Zheng, Zhixiang Liao, Joseph J Locascio, et al.
Neurology|March 16, 2021
National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy SyndromeDouglas I Katz, Charles Bernick, David W Dodick, et al.
Journal of Neurotrauma|November 11, 2025
Diffusion Alterations at the Gray Matter/White Matter Boundary in Traumatic Encephalopathy SyndromeTim L T Wiegand, Lara Pankatz, Hector Arciniega, et al.
Neurology|January 2, 2024
Association of Vascular Risk Factors and CSF and Imaging Biomarkers With White Matter Hyperintensities in Former American Football PlayersMonica T Ly, Fatima Tuz-Zahra, Yorghos Tripodis, et al.
Journal of Neuropathology and Experimental Neurology|April 18, 2023
Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathyThomas G Beach, Lucia I Sue, Sarah Scott, et al.
Neurology|September 4, 2015
Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathiesCatherine Labbé, Kotaro Ogaki, Oswaldo Lorenzo-Betancor, et al.
The Lancet. Neurology|July 24, 2021
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorderMitchell G Miglis, Charles H Adler, Elena Antelmi, et al.
Alzheimer'S Research & Therapy|August 13, 2021
Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research ProjectMichael L Alosco, Megan L Mariani, Charles H Adler, et al.
Plos One|June 26, 2019
Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body diseaseMichael Malek-Ahmadi, Thomas G Beach, Edward Zamrini, et al.
Pageof 83

Showing results (811-820 of 830) with videos related to

Sort By:
Pageof 83
Brain Communications|June 15, 2026
Dose-dependent white matter changes associated with repetitive head impacts in former American football playersHector Arciniega, Alana Wickham, Brian Szekely, et al.
Science Translational Medicine|October 8, 2010
PGC-1α, a potential therapeutic target for early intervention in Parkinson's diseaseBin Zheng, Zhixiang Liao, Joseph J Locascio, et al.
Neurology|March 16, 2021
National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy SyndromeDouglas I Katz, Charles Bernick, David W Dodick, et al.
Journal of Neurotrauma|November 11, 2025
Diffusion Alterations at the Gray Matter/White Matter Boundary in Traumatic Encephalopathy SyndromeTim L T Wiegand, Lara Pankatz, Hector Arciniega, et al.
Neurology|January 2, 2024
Association of Vascular Risk Factors and CSF and Imaging Biomarkers With White Matter Hyperintensities in Former American Football PlayersMonica T Ly, Fatima Tuz-Zahra, Yorghos Tripodis, et al.
Journal of Neuropathology and Experimental Neurology|April 18, 2023
Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathyThomas G Beach, Lucia I Sue, Sarah Scott, et al.
Neurology|September 4, 2015
Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathiesCatherine Labbé, Kotaro Ogaki, Oswaldo Lorenzo-Betancor, et al.
The Lancet. Neurology|July 24, 2021
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorderMitchell G Miglis, Charles H Adler, Elena Antelmi, et al.
Alzheimer'S Research & Therapy|August 13, 2021
Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research ProjectMichael L Alosco, Megan L Mariani, Charles H Adler, et al.
Plos One|June 26, 2019
Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body diseaseMichael Malek-Ahmadi, Thomas G Beach, Edward Zamrini, et al.
Pageof 83